[Development of animal model with JC virus infection and the therapeutic study].
Nakagawa
Tomoko
T
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D002478:Cells, Cultured; D003094:Collagen; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D016503:Drug Delivery Systems; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D007577:JC Virus / Q000235:genetics*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000628:therapy; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D034741:RNA, Small Interfering / Q000008:administration & dosage*
D000998:Antiviral Agents; D034741:RNA, Small Interfering; C059821:atelocollagen; D003561:Cytarabine; D003094:Collagen